Quantum BioPharma Ltd. (QNTM)

Quantum BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.52	6	2.76	16.98	35.26	17.52
Short-Term Investments	0.02	1.2	0.76	-	0.16	-
Cash & Short-Term Investments	3.54	7.2	3.51	16.98	35.42	17.52
Cash Growth	69.31%	104.89%	-79.31%	-52.06%	102.10%	193.66%
Accounts Receivable	3.02	3.43	7.19	0.02	-	-
Other Receivables	0.39	0.37	0.23	0.37	0.5	0.16
Receivables	3.41	3.81	7.42	0.4	0.5	0.16
Inventory	0.09	0.12	-	-	-	-
Prepaid Expenses	0.12	0.04	0.12	0.16	0.76	0.57
Other Current Assets	2.77	0.89	0.03	0.31	9.25	8.61
Total Current Assets	9.93	12.05	11.09	17.85	45.93	26.87
Property, Plant & Equipment	0.11	0.13	0.12	0.26	0.17	-
Long-Term Investments	0	0	0.01	0.83	0.66	1.68
Other Intangible Assets	4.83	4.93	5.36	12.04	16.2	13.42
Long-Term Accounts Receivable	-	-	0.91	7.43	-	-
Total Assets	14.87	17.12	17.47	38.41	62.96	41.97
Accounts Payable	1.32	3.25	3.24	2.76	3	2.06
Accrued Expenses	1.04	1.11	0.95	4.35	4.46	1.62
Short-Term Debt	1.09	0.62	0.3	0.3	0.3	0.38
Current Portion of Long-Term Debt	0.16	0.15	-	-	-	-
Current Portion of Leases	0.04	0.05	0.04	0.18	0.12	0.05
Current Unearned Revenue	1	1	-	-	-	-
Other Current Liabilities	5.71	0.49	0.03	0.24	0.83	1.46
Total Current Liabilities	10.34	6.68	4.57	7.83	8.7	5.58
Long-Term Leases	-	-	-	0.04	0.13	0.08
Total Liabilities	10.34	6.68	4.57	7.87	8.83	5.66
Common Stock	153.04	150.47	137.78	143.41	152.32	103.21
Additional Paid-In Capital	31.96	31.07	30.23	28.5	22.58	18.79
Retained Earnings	-180.69	-172.11	-157.91	-144.16	-126.15	-90.87
Comprehensive Income & Other	1.43	2.05	3.14	2.8	5.38	5.18
Total Common Equity	5.73	11.48	13.24	30.54	54.13	36.31
Minority Interest	-1.2	-1.04	-0.33	-	-	-
Shareholders' Equity	4.53	10.44	12.91	30.54	54.13	36.31
Total Liabilities & Equity	14.87	17.12	17.47	38.41	62.96	41.97
Total Debt	1.28	0.82	0.34	0.52	0.56	0.51
Net Cash (Debt)	2.26	6.37	3.17	16.46	34.86	17.01
Net Cash Growth	54.03%	100.80%	-80.72%	-52.77%	104.90%	288.50%
Net Cash Per Share	1.41	5.61	5.21	27.63	64.84	91.82
Filing Date Shares Outstanding	2.91	2.71	0.62	0.63	0.59	0.54
Total Common Shares Outstanding	2.71	2.3	0.61	0.59	0.62	0.29
Working Capital	-0.41	5.37	6.52	10.02	37.23	21.29
Book Value Per Share	2.11	4.99	21.85	51.56	86.98	123.17
Tangible Book Value	0.9	6.55	7.88	18.5	37.93	22.88
Tangible Book Value Per Share	0.33	2.85	13.01	31.23	60.95	77.63

Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q